Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

BETRF

BetterLife Pharma Inc.

Pharmaceutical Preparations · SIC 2834CIK 1464165Held by 0 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2018
—
Net Income FY2018
$0
EPS (Basic, as reported)
—
Net Margin FY2018
—
ROE FY2018
267.0%
Total Equity
$0
Shares Out
145M
Business description

BetterLife Pharma Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2018; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itNet income: (1) → 0
Fiscal yearFY2009FY2010FY2011FY2012FY2013⚑FY2015⚑FY2016FY2017FY2018
Research & development———0————0
General & administrative——0000(1)(2)0
Total operating expenses—————0(9)(6)(1)
Operating income—————0(9)(6)(1)
Interest expense———000—00
Other income (expense), net——(3)20————
Net income(1)0(3)10(1)(9)(6)0
EPS — basic—————($0.10)($0.11)——
EPS — diluted—————($0.10)($0.11)——
Shares outstanding — basic (M)——2834361278——
  • ⚑ Weighted-average shares changed ÷3.03 between FY2013 and FY2015 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×6.50 between FY2015 and FY2016 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.